Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure-Reference-Cited by-同舟云学术

Effect of Age, Weight, and CYP2C19 Genotype on Escitalopram Exposure

Published:2010-01 Issue:1 Volume:50 Page:62-72
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Jin Yuyan,Pollock Bruce G.,Frank Ellen,Cassano Giovanni B.,Rucci Paola,Müller Daniel J.,Kennedy James L.,Forgione Rocco Nicola,Kirshner Margaret,Kepple Gail,Fagiolini Andrea,Kupfer David J.,Bies Robert R.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Managing depressive and anxiety disorders with escitalopram;Thase;Expert Opin Pharmacother,2006

2. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys;Demyttenaere;JAMA,2004

3. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients;Burke;J Clin Psychiatry,2002

4. Escitalopram continuation treatment prevents relapse of depressive episodes;Rapaport;J Clin Psychiatry,2004

5. Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care;Wade;Int Clin Psychopharmacol,2002

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population;British Journal of Clinical Pharmacology;2024-06-26

2. Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine;Pharmaceutics;2024-06-06

3. Escitalopram population pharmacokinetics and remedial strategies based on CYP2C19 phenotype;Journal of Affective Disorders;2024-02

4. Escitalopram-induced Extrapyramidal Symptoms – A Case Series;Annals of Indian Psychiatry;2023-12-21

5. Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients;Clinical Pharmacokinetics;2023-09-27